Diabetes Technology Starts: Amiad Fredman from Sweet Spot on Remote CGM and Diabetes Data Management
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
-
Narrado por:
-
De:
In this second episode of our Diabetes Technology Starts series, we speak with Sweet Spot co-founder and physician Amiad Fredman about turning continuous glucose monitoring (CGM) data into proactive diabetes care. He explains how Sweet Spot partners with endocrinology and primary care practices to remotely monitor patients using tools like the Glycemia Risk Index (GRI) to triage risk and guide timely insulin adjustments between visits without requiring new devices or added work from patients. We also discuss the role of AI in analyzing glucose data and streamlining clinical workflows, as well as Sweet Spot’s provider-aligned business model that supports sustainable remote monitoring.
Todavía no hay opiniones